1Ladenson PW, Singer PA, Ain KB, et al. American thyroid association guidelines for detection of thyroid dysfunction. Arch Intern Med,2000,160:1573-1575.
2Faber J, Winberg N, Schifter S, et al. Haemodynamic changes following treatment of subclinical and overt hyperthyroidism. Eur J Endocrinol,2001,145: 391-396.
3Kuneda Y, Inaba M, Tahara H, et al. Persistent increase in bone turnover in Graves patients with subclinical hyperthyroidism. J Clin Endocrinol Metab,2000,85:4157-4161.
4Mudde AH, Honben AJHM, Nieuwenhuijizen KAC. Bone metabolism during antithyroid treatment of endogenous subclinical hyperthyroidism. Clin Endocrinol ,1994 ,41: 421 -424.
5Ferretti E, Persani L, Jaffrain - Rea ML, et al. Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism. J Clin Endocrinol Metab,1999,84:924-929.
6Canaris GJ, Manowitz NR, Mayor GM, et al. The colorado thyroid disease prevalence study. Arch Intern Med,2000,160:526 -534.
7Mnller AF, Drexhage HA, Berghout A, et al. Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: recent insights and consequences for antenatal and postnatal care. Endocr Rev,2001,22(5): 605-630.
8Basaria M, Graf H, Cooper DS, et al. Use of recombinant thyrotropin in the follow-up of patients with differentiated thyroid cancer. Am J Med,2002,112:721-725.